Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Pinto
Human Rhinovirus 16 Causes Golgi Apparatus Fragmentation Without Blocking Protein Secretion
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Laparascopic Surgery of Choledocholithiasis. Comparison of Curative and Conservative Approaches
HPB
Hepatology
Gastroenterology
Effects of Aerobic Training on Cognition and Brain Glucose Metabolism in Subjects With MCI
Journal of the Neurological Sciences
Neurology
Constructing and Using Multimodal Narratives to Research in Science Education: Contributions Based on Practical Classroom
Research in Science Education
Education
Phase Ii Fil-Ptcl13 Study of Romidepsin-Choep Followed by High-Dose Chemotherapy and Transplantation in Untreated Peripheral T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Augment Phase Iii Study: Lenalidomide/Rituximab (R2 ) Improved Efficacy Over Rituximab/Placebo in Relapsed/Refractory Follicular Patients Irrespective of Pod24 Status
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response Oriented Maintenance Therapy in Advanced Follicular Lymphoma. Results of the Interim Analysis of the Foll12 Trial Conducted by the Fondazione Italiana Linfomi.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A First-In-Human Trial of the Novel Multi-Action Therapy Tinostamustine (Edo-S101) in Patients With Relapsed/Refractory (R/R) Hodgkin Lymphoma (Hl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2 ) VERSUS R PLUS PLACEBO
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
1
2
›